Metonitazene

Metonitazene

Metonitazene

Metonitazene is a potent synthetic opioid analgesic drug that is structurally related to etonitazene and has been sold online as a designer drug. It acts as a μ-opioid agonist with high affinity for the μ-opioid receptor. Metonitazene has been reported to produce similar effects to other opioids such as morphine and fentanyl.

History

Metonitazene was first synthesized in the 1950s by a team of researchers looking to develop new opioid compounds. It gained popularity in the online drug market in the late 2010s due to its potent analgesic effects and high affinity for the μ-opioid receptor.

Pharmacology

Metonitazene acts as a potent agonist at the μ-opioid receptor, leading to its analgesic effects. It has a high affinity for the receptor, making it a strong opioid drug. Metonitazene is known to produce effects similar to other opioids, including pain relief, sedation, and euphoria.

Side Effects

As with other opioids, metonitazene can cause a range of side effects, including respiratory depression, constipation, drowsiness, and potential for addiction and overdose. Due to its potency, metonitazene poses a high risk of overdose and should be used with caution.

Legal Status

Metonitazene is not approved for medical use in any country and is classified as a controlled substance in many jurisdictions. Its sale and possession are illegal in most places due to its high potential for abuse and addiction.

See also

• Opioid
• Designer drug
• Etonitazene